Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
Status:
Completed
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
Bone is lost rapidly and fractures occur in 10-20% of patients who receive organ transplants
within 2 years. The purpose of this study is to evaluate long-term effects of a
pamidronate-vitamin D-calcium regimen on bone loss, fractures, and safety in recipients of
kidney and heart transplants.
Phase:
N/A
Details
Lead Sponsor:
Providence Health & Services
Collaborators:
Ochsner Health System The Heart Institute of Spokane University of Washington
Treatments:
Calcium Calcium Carbonate Calcium, Dietary Ergocalciferols Pamidronate Vitamin D Vitamins